Prospective high-throughput genome profiling of advanced cancers: results of the PERMED-01 clinical trial

MLA

Renaud Sabatier, et al. Prospective High-Throughput Genome Profiling of Advanced Cancers: Results of the PERMED-01 Clinical Trial. Dec. 2021. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....a6fbe58a797962887c649f4db544c93e&authtype=sso&custid=ns315887.

APA

Renaud Sabatier, Magali Provansal, Patrice Viens, Patrick Sfumato, Séverine Garnier, Jihane Pakradouni, Flora Poizat, Emilien Billon, Pascal Finetti, Arnaud Guille, Jean-Marc Extra, Nadine Carbuccia, Emilie Mamessier, Olivier Turrini, Anthony Gonçalves, Cornel Popovici, Fabrice Andre, Eric Lambaudie, Cecile Vicier, … Marine Gilabert. (2021). Prospective high-throughput genome profiling of advanced cancers: results of the PERMED-01 clinical trial.

Chicago

Renaud Sabatier, Magali Provansal, Patrice Viens, Patrick Sfumato, Séverine Garnier, Jihane Pakradouni, Flora Poizat, et al. 2021. “Prospective High-Throughput Genome Profiling of Advanced Cancers: Results of the PERMED-01 Clinical Trial,” December. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....a6fbe58a797962887c649f4db544c93e&authtype=sso&custid=ns315887.